Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-adrenergic function in a congestive cardiomyopathy model.

N A Staley, S Einzig, G R Noren

    The American Journal of Physiology
    |February 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cardiac hemangioma of the right atrium in a neonate: fetal management and expedited surgical resection.

    Images in paediatric cardiology·2012
    Same author

    Increased susceptibility to gingival colonization by specific HACEK microbes in children with congenital heart disease.

    The Journal of clinical pediatric dentistry·2001
    Same author

    Estrogen-induced relaxation in bovine coronary arteries in vitro: evidence for a new mechanism.

    The West Virginia medical journal·2001
    Same author

    Fetal echocardiography at West Virginia University: a seven-year experience.

    The West Virginia medical journal·2000
    Same author

    Comparative study of clinical evaluation of heart murmurs by general pediatricians and pediatric cardiologists.

    Clinical pediatrics·1999
    Same author

    Nebulized nitroglycerin in children with pulmonary hypertension secondary to congenital heart disease.

    The West Virginia medical journal·1999

    This study examines how the heart's signaling system, specifically the beta-adrenergic pathway, changes in turkeys prone to heart failure. Researchers found that defects in this system appear early, even before the heart begins to enlarge, and contribute to poor heart function as the disease progresses.

    Area of Science:

    • Cardiovascular physiology and beta-adrenergic signaling pathways
    • Avian models of congestive cardiomyopathy research

    Background:

    The precise molecular origins of heart failure in avian models remain poorly understood despite extensive characterization of cardiac structure. Prior research has shown that signaling pathways often become dysregulated during progressive cardiac remodeling. No prior work had resolved whether these molecular changes precede or follow the physical enlargement of the heart muscle. That uncertainty drove the need to examine specific signaling components in a controlled genetic model. Researchers have long suspected that the heart's ability to respond to stress is compromised in these conditions. However, the exact timing of these signaling failures relative to structural changes has stayed elusive. This gap motivated a detailed investigation into the beta-adrenergic-adenylate cyclase system. By comparing diseased birds to healthy controls, investigators sought to clarify the sequence of these physiological events.

    Purpose Of The Study:

    This study aims to characterize the beta-adrenergic-adenylate cyclase system within a specific avian model of congestive cardiomyopathy. Researchers sought to determine if signaling abnormalities correlate with the physical performance of the heart. The team investigated whether these molecular defects appear before or after the onset of cardiac dilatation. They also examined how systemic hemodynamics respond to pharmacological stimulation in diseased subjects. By comparing birds at different ages, the authors intended to isolate the timing of signaling failures. The project focused on quantifying enzyme activity and receptor density to explain reduced cardiac function. This work addresses the lack of clarity regarding the sequence of events in heart failure progression. The researchers aimed to establish a direct link between cellular signaling capacity and measurable cardiac output.

    Keywords:
    cardiac physiologybeta-adrenergic receptorsheart failure modelhemodynamic response

    Frequently Asked Questions

    The researchers propose that a global defect in the beta-adrenergic-adenylate cyclase system causes the heart to lose its ability to increase contraction strength and heart rate when exposed to isoproterenol infusion.

    The study utilizes isoproterenol, a synthetic catecholamine, to stimulate the beta-adrenergic receptors and measure the subsequent adenylate cyclase activity and hemodynamic responses in the birds.

    The researchers state that the presence of cardiac dilatation is necessary to observe the full global defect, as birds without dilatation show only partial reductions in specific signaling components.

    Related Experiment Videos

    Main Methods:

    Investigators employed a controlled avian model to assess cardiac signaling across different developmental stages. They measured enzyme activity levels by stimulating heart tissue samples with specific chemical agents. Researchers performed echocardiography to determine the left ventricular shortening fraction in individual birds. The team infused isoproterenol at a constant rate to evaluate systemic hemodynamic responses. They quantified the density of beta-adrenergic receptors using binding assays on cardiac membranes. Statistical comparisons between diseased and healthy groups relied on linear regression to establish correlations. The study design included both young birds without structural changes and older birds with advanced disease. This approach allowed for the temporal mapping of signaling dysfunction relative to physical heart remodeling.

    Main Results:

    The strongest finding indicates that isoproterenol-stimulated, sodium fluoride-stimulated, and basal enzyme activities dropped to 69%, 72%, and 86% of control values in diseased birds. Initial left ventricular shortening fraction in the cardiomyopathy group measured only 72% of the healthy control value. Diseased birds exhibited an initial heart rate that was 112% of the control group. During stress testing, control birds showed increased contraction and heart rate, whereas diseased birds with dilatation displayed no change. In young birds lacking structural enlargement, sodium fluoride-stimulated activity decreased to 70% of control levels. Basal and isoproterenol-stimulated activities remained unchanged in these younger subjects. Statistical analysis revealed a direct correlation between shortening fraction and the density of beta-adrenergic receptors. These results demonstrate a clear progression of signaling failure from early molecular changes to severe global defects.

    Conclusions:

    The authors propose that signaling defects emerge early in the progression of this specific cardiomyopathy. These molecular alterations exist before any visible signs of heart chamber enlargement appear in the birds. When the heart becomes severely dilated, the entire signaling pathway shows widespread functional impairment. This global defect directly correlates with the heart's inability to increase its contraction force under stress. The researchers suggest that the diminished responsiveness to stimulation is a hallmark of the advanced disease state. These findings offer a clear link between cellular signaling capacity and overall cardiac performance. The study highlights how early molecular changes may set the stage for later structural failure. Future investigations could explore whether correcting these early signaling deficits prevents the subsequent development of cardiac dilatation.

    The authors use linear regression analysis to relate the left ventricular shortening fraction to the density of beta-adrenergic receptors and various adenylate cyclase activity levels.

    The researchers measured the left ventricular shortening fraction, which was significantly lower in diseased birds, reaching only 72% of the control value in the congestive cardiomyopathy model.

    The authors propose that the observed signaling abnormalities represent a primary defect that precedes the physical enlargement of the heart chambers.